Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Transverse B-Lynch in Management of Placenta Accreta

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02943421
Recruitment Status : Completed
First Posted : October 24, 2016
Last Update Posted : June 27, 2018
Sponsor:
Information provided by (Responsible Party):
Ahmed Mohamed Abbas, Assiut University

Brief Summary:
Placenta accreta is considered a severe pregnancy complication that may be associated with massive and potentially life-threatening intrapartum and postpartum hemorrhage. Life-threatening bleeding is the most common complication to be associated with this condition; the average blood loss at time of delivery is reported to be 3000-5500 mL, which leads to significant postoperative morbidity and death.

Condition or disease Intervention/treatment
Decrease Maternal Morbidity Procedure: Transverse B-Lynch suture

Layout table for study information
Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the Efficacy of Transverse B-Lynch in Management of Placenta Accreta
Actual Study Start Date : December 1, 2016
Actual Primary Completion Date : February 3, 2018
Actual Study Completion Date : May 5, 2018

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Estimated intraoperative blood loss [ Time Frame: 30 min ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
the study encompassing women managed by conservative transverse B-Lynch during cesarean section due to placenta accreta
Criteria

Inclusion Criteria:

1. All pregnant women with placenta previa as diagnosed by ultrasound with suspicion of abnormal placentation by Doppler us, confirmed intraoperatively undergoing either emergent or elective cesarean

Exclusion Criteria:

  1. Patients who will be managed by hysterectomy
  2. Patients who will be managed by conservative leaving the placenta in-situ

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02943421


Locations
Layout table for location information
Egypt
Ahmed Abbas
Assiut, Cairo, Egypt, 002
Sponsors and Collaborators
Assiut University

Layout table for additonal information
Responsible Party: Ahmed Mohamed Abbas, Dr, Assiut University
ClinicalTrials.gov Identifier: NCT02943421     History of Changes
Other Study ID Numbers: MAP
First Posted: October 24, 2016    Key Record Dates
Last Update Posted: June 27, 2018
Last Verified: June 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Placenta Accreta
Obstetric Labor Complications
Pregnancy Complications
Placenta Diseases